BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 22781907)

  • 21. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.
    Shah C; Johnson EB; Everett E; Tamimi H; Greer B; Swisher E; Goff B
    Gynecol Oncol; 2005 Dec; 99(3):564-70. PubMed ID: 16246402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
    Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
    Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
    J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
    Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
    Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution.
    Dahdaleh FS; Calva-Cerqueira D; Carr JC; Liao J; Mezhir JJ; O'Dorisio TM; Howe JR
    Ann Surg Oncol; 2012 Mar; 19(3):966-72. PubMed ID: 21845496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.
    Falconi M; Zerbi A; Crippa S; Balzano G; Boninsegna L; Capitanio V; Bassi C; Di Carlo V; Pederzoli P
    Ann Surg Oncol; 2010 Jun; 17(6):1621-7. PubMed ID: 20162460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.
    Prenzel KL; Hölscher AH; Vallböhmer D; Drebber U; Gutschow CA; Mönig SP; Stippel DL
    Eur J Surg Oncol; 2010 Oct; 36(10):993-6. PubMed ID: 20594789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
    Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
    Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Yuasa Y; Kondo N; Ohge H; Sueda T
    J Am Coll Surg; 2010 Aug; 211(2):196-204. PubMed ID: 20670857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
    Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
    Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
    Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
    Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
    J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.